Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting symbols : Zyne save search
Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting
Published: 2023-08-08 (Crawled : 20:00) - globenewswire.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 3.67%
H: 0.28%
C: -7.02%
pharmaceuticals meeting
Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting
Published: 2023-07-25 (Crawled : 21:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -0.51%
H: 4.4%
C: 2.77%
pharmaceuticals meeting
Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting
Published: 2023-06-28 (Crawled : 20:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -0.67%
H: 0.18%
C: -2.26%
pharmaceuticals meeting
Zynerba Pharmaceuticals Announces Partial Adjournment of Annual Meeting
Published: 2023-06-13 (Crawled : 20:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -0.57%
H: 2.27%
C: -2.33%
pharmaceuticals meeting
Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
Published: 2023-05-23 (Crawled : 11:00) - globenewswire.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 1.53%
H: 1.23%
C: -0.12%
pharmaceuticals meeting
Zynerba Pharmaceuticals Announces Positive Long-Term Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at the Annual Meeting of the American College of Neuropsychopharmacology
Published: 2022-12-05 (Crawled : 13:00) - globenewswire.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 1.17%
H: 6.14%
C: 2.8%
pharmaceuticals inspire meeting trial positive
Zynerba Pharmaceuticals Announces Poster Presentation at the Annual Meeting of the American College of Neuropsychopharmacology
Published: 2022-11-29 (Crawled : 12:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.29%
H: 0.33%
C: -5.55%
pharmaceuticals meeting presentation
Zynerba Pharmaceuticals Presents Data on Zygel™ at the American Society of Clinical Psychopharmacology Annual Meeting
Published: 2022-06-01 (Crawled : 10:12) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 1.31%
H: 2.05%
C: -6.7%
meeting zygel
Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
Published: 2022-05-24 (Crawled : 12:00) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -1.55%
H: 2.03%
C: -5.95%
Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel™ in Children and Adolescents with Fragile X Syndrome (FXS) at the International Society for Autism Research Annual Meeting
Published: 2022-05-11 (Crawled : 18:00) - globenewswire.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 4.59%
H: 0.88%
C: -16.66%
research children international zygel
Zynerba Pharmaceuticals Announces Podium Presentation at the International Society for Autism Research Annual Meeting
Published: 2022-05-09 (Crawled : 21:00) - globenewswire.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 2.63%
H: 5.13%
C: -6.84%
research presentation international
Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel™ in Children and Adolescents with Fragile X Syndrome (FXS) at the 2022 Society of Biological Psychiatry Annual Meeting
Published: 2022-05-02 (Crawled : 12:00) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.71%
H: 3.55%
C: 3.55%
children zygel
Zynerba Pharmaceuticals Announces Presentation of Poster at the 2022 Society of Biological Psychiatry Annual Meeting
Published: 2022-04-21 (Crawled : 12:20) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 4.62%
H: 0.0%
C: 0.0%
presentation
Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting - June 30, 2021
Published: 2021-06-30 (Crawled : 12:00) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -0.18%
H: 0.74%
C: -2.22%
Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting
Published: 2021-06-30 (Crawled : 11:00) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -0.18%
H: 0.74%
C: -2.22%
Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting
Published: 2021-06-09 (Crawled : 20:00) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.18%
H: 0.36%
C: -3.04%
Zynerba Pharmaceuticals Announces Acceptance of Poster at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting
Published: 2021-06-04 (Crawled : 12:00) - globenewswire.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.1%
H: 1.64%
C: -0.48%
Zynerba Pharmaceuticals Announces Presentation of Efficacy and Safety Findings in Children and Adolescents with Autism Spectrum Disorder (ASD) and Related Disorders at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Published: 2021-06-03 (Crawled : 14:00) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -1.7%
H: 6.72%
C: -0.58%
presentation children lsd
Zynerba Pharmaceuticals Announces Acceptance of Poster at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Published: 2021-05-27 (Crawled : 12:00) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.38%
H: 3.53%
C: 0.76%
Zynerba Pharmaceuticals Presents Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting
Published: 2021-04-29 (Crawled : 18:00) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -1.83%
H: 1.86%
C: -2.13%
Gainers vs Losers
| 76% | 24% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
HKIT | $1.33 30.39% 27.14% 39K
|
Technology Services
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
PEGY | $0.0566 23.58% 15.65% 11M
|
Manufacturing
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
BOF | $1.17 6.36% 14.73% 15K
|
LUCY | $0.2545 9.93% 13.94% 66K
|
n/a
PEB 4 | $15.45 2.45% 10.46% 130
|
Finance
MARA | $19.44 10.77% 10.28% 630K
|
Commercial Services
TSLA | News | $144.68 1.85% 9.01% 93M
|
Consumer Durables
Your saved searches
Save your searches and get alerts when important news are released.